Empower Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Empower Advisory Group's BMY Position: Q3 2026 in Review
Empower Advisory Group reduced its Bristol-Myers Squibb (BMY) stake by 9.5% in Q3 2026, selling an estimated $40.7K and leaving 6,155 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #386.
Empower Advisory Group first reported a position in BMY in Q1 2023 and has held it in 15 quarters since. The position peaked at $746K in Q1 2023. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Empower Advisory Group held 6,155 shares of Bristol-Myers Squibb worth $384K as of Q3 2026.
- Empower Advisory Group sold 644 Bristol-Myers Squibb shares in Q3 2026, an estimated $40.7K.
- Bristol-Myers Squibb made up ﹤0.01% of Empower Advisory Group's portfolio in Q3 2026, its #386 holding.
- Empower Advisory Group first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 15 quarters since.
- Empower Advisory Group's Bristol-Myers Squibb position peaked at $746K in Q1 2023.
- 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Empower Advisory Group's 13F filing for Q3 2026, filed 13 Nov 2026.